Insufficient scRNA-seq data for expression of POU4F2 at single-cell level.
Insufficient scRNA-seq data for expression of POU4F2 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 13% | 2.20 | 31 / 245 | 0% | 0 | 0 / 502 |
brain | 6% | 3.43 | 158 / 2642 | 2% | 0.08 | 16 / 705 |
adrenal gland | 0% | 0 | 0 / 258 | 5% | 0.19 | 11 / 230 |
intestine | 3% | 0.74 | 26 / 966 | 0% | 0.01 | 1 / 527 |
esophagus | 2% | 0.44 | 28 / 1445 | 1% | 0.02 | 1 / 183 |
stomach | 1% | 0.11 | 3 / 359 | 1% | 0.01 | 2 / 286 |
eye | 0% | 0 | 0 / 0 | 1% | 0.08 | 1 / 80 |
pancreas | 0% | 0 | 0 / 328 | 1% | 0.02 | 2 / 178 |
breast | 1% | 0.10 | 3 / 459 | 0% | 0.00 | 2 / 1118 |
skin | 0% | 0 | 0 / 1809 | 1% | 0.03 | 3 / 472 |
uterus | 0% | 0 | 0 / 170 | 0% | 0.01 | 2 / 459 |
lung | 0% | 0 | 0 / 578 | 0% | 0.01 | 5 / 1155 |
bladder | 0% | 0 | 0 / 21 | 0% | 0.01 | 2 / 504 |
thymus | 0% | 0.05 | 2 / 653 | 0% | 0 | 0 / 605 |
muscle | 0% | 0.01 | 1 / 803 | 0% | 0 | 0 / 0 |
kidney | 0% | 0 | 0 / 89 | 0% | 0.00 | 1 / 901 |
adipose | 0% | 0.03 | 1 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 0% | 0.01 | 1 / 1335 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
heart | 0% | 0 | 0 / 861 | 0% | 0 | 0 / 0 |
liver | 0% | 0 | 0 / 226 | 0% | 0 | 0 / 406 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ovary | 0% | 0 | 0 / 180 | 0% | 0 | 0 / 430 |
peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_2000679 | Biological process | positive regulation of transcription regulatory region DNA binding |
GO_0007605 | Biological process | sensory perception of sound |
GO_0046326 | Biological process | positive regulation of glucose import |
GO_0032869 | Biological process | cellular response to insulin stimulus |
GO_0090259 | Biological process | regulation of retinal ganglion cell axon guidance |
GO_0045773 | Biological process | positive regulation of axon extension |
GO_0000165 | Biological process | MAPK cascade |
GO_0007507 | Biological process | heart development |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0071392 | Biological process | cellular response to estradiol stimulus |
GO_0050885 | Biological process | neuromuscular process controlling balance |
GO_0060041 | Biological process | retina development in camera-type eye |
GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
GO_0043433 | Biological process | negative regulation of DNA-binding transcription factor activity |
GO_1902870 | Biological process | negative regulation of amacrine cell differentiation |
GO_0045672 | Biological process | positive regulation of osteoclast differentiation |
GO_0030182 | Biological process | neuron differentiation |
GO_0045597 | Biological process | positive regulation of cell differentiation |
GO_0071345 | Biological process | cellular response to cytokine stimulus |
GO_1904178 | Biological process | negative regulation of adipose tissue development |
GO_0043068 | Biological process | positive regulation of programmed cell death |
GO_0072332 | Biological process | intrinsic apoptotic signaling pathway by p53 class mediator |
GO_1990791 | Biological process | dorsal root ganglion development |
GO_0048675 | Biological process | axon extension |
GO_0045596 | Biological process | negative regulation of cell differentiation |
GO_0051090 | Biological process | regulation of DNA-binding transcription factor activity |
GO_0031290 | Biological process | retinal ganglion cell axon guidance |
GO_0030520 | Biological process | estrogen receptor signaling pathway |
GO_0007411 | Biological process | axon guidance |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0016607 | Cellular component | nuclear speck |
GO_0000791 | Cellular component | euchromatin |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005737 | Cellular component | cytoplasm |
GO_0000785 | Cellular component | chromatin |
GO_0005667 | Cellular component | transcription regulator complex |
GO_0005634 | Cellular component | nucleus |
GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO_1990841 | Molecular function | promoter-specific chromatin binding |
GO_0001228 | Molecular function | DNA-binding transcription activator activity, RNA polymerase II-specific |
GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
GO_0001227 | Molecular function | DNA-binding transcription repressor activity, RNA polymerase II-specific |
GO_0002039 | Molecular function | p53 binding |
GO_0005515 | Molecular function | protein binding |
Gene name | POU4F2 |
Protein name | POU domain, class 4, transcription factor 2 (Brain-specific homeobox/POU domain protein 3B) (Brain-3B) (Brn-3B) |
Synonyms | BRN3B |
Description | FUNCTION: Tissue-specific DNA-binding transcription factor involved in the development and differentiation of target cells . Functions either as activator or repressor modulating the rate of target gene transcription through RNA polymerase II enzyme in a promoter-dependent manner . Binds to the consensus octamer motif 5'-AT[A/T]A[T/A]T[A/T]A-3' of promoter of target genes. Plays a fundamental role in the gene regulatory network essential for retinal ganglion cell (RGC) differentiation. Binds to an octamer site to form a ternary complex with ISL1; cooperates positively with ISL1 and ISL2 to potentiate transcriptional activation of RGC target genes being involved in RGC fate commitment in the developing retina and RGC axon formation and pathfinding. Inhibits DLX1 and DLX2 transcriptional activities preventing DLX1- and DLX2-mediated ability to promote amacrine cell fate specification. In cooperation with TP53 potentiates transcriptional activation of BAX promoter activity increasing neuronal cell apoptosis. Negatively regulates BAX promoter activity in the absence of TP53. Acts as a transcriptional coactivator via its interaction with the transcription factor ESR1 by enhancing its effect on estrogen response element (ERE)-containing promoter. Antagonizes the transcriptional stimulatory activity of POU4F1 by preventing its binding to an octamer motif. Involved in TNFSF11-mediated terminal osteoclast differentiation (By similarity). . |
Accessions | Q12837 ENST00000281321.3 [Q12837-1] |